What does the 2-year follow-up tell us about the use of pembrolizumab for advanced bladder cancer?
Long-term follow-up data is the real determinant of the efficacy of novel therapies. Here, Robert Jones, PhD, of the University of Glasgow & Beatson West of Scotland Cancer Centre, Glasgow, UK, di...
Author: VJOncology
Added: 02/19/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts